Advanced Computing in the Age of AI|Friday, April 3, 2020
  • Subscribe to EnterpriseAI Weekly Updates:  Subscribe by email

drug discovery

Insilico, Pfizer Join AI Forces on Drug Discovery

Previous attempts to apply AI to drug discovery have yielded mixed results. For example, IBM ended sales last year of its Watson AI software used by pharmaceutical firms for ...Full Article

Emerging AI Business Model Promotes Distributed ML

Pausing at the end of 2019 to take stock of where enterprise AI stands, a new business model floated over the last year encourages distributed model training through the ...Full Article

Microsoft, Novartis Team on AI-based Therapies

Swiss pharmaceutical giant Novartis is teaming with Microsoft on a medical AI effort aimed at developing new data-driven techniques for drug discovery and development of specific therapies. The multi-year ...Full Article

IBM’s Watson Retreat Highlights AI Shortcomings for Medical Research

Amid reports of declining sales and growing skepticism about the utility of machine learning for complex medical research, IBM will reportedly end sales of its Watson AI software used ...Full Article

Nvidia Doubles Down on Medical AI

Nvidia is collaborating with medical groups to push GPU-powered AI tools into clinical settings, including radiology and drug discovery. The GPU leader said Monday (April 8) it will collaborate ...Full Article
Do NOT follow this link or you will be banned from the site!